Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.

Rose, Ronald; Gartland, Margaret; Li, Zhufang; Zhou, Nannan; Cockett, Mark; Beloor, Jagadish; Lataillade, Max; Ackerman, Peter; Krystal, Mark

Rose, Ronald; Gartland, Margaret; Li, Zhufang; Zhou, Nannan; Cockett, Mark; Beloor, Jagadish; Lataillade, Max; Ackerman, Peter; Krystal, Mark.

Affiliation

Rose R; ViiV Healthcare, Branford, Connecticut.
Gartland M; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
Li Z; ViiV Healthcare, Branford, Connecticut.
Zhou N; ViiV Healthcare, Branford, Connecticut.
Cockett M; ViiV Healthcare, Branford, Connecticut.
Beloor J; ViiV Healthcare, Branford, Connecticut.
Lataillade M; ViiV Healthcare, Branford, Connecticut.
Ackerman P; ViiV Healthcare, Branford, Connecticut.
Krystal M; ViiV Healthcare, Branford, Connecticut.

AIDS ; 36(1): 11-18, 2022 01 01.

Article in En | MEDLINE | ID: mdl-34628442

Subject(s)

Anti-HIV Agents; HIV Infections; Anti-HIV Agents/therapeutic use; Antibodies, Monoclonal/pharmacology; CCR5 Receptor Antagonists/pharmacology; CCR5 Receptor Antagonists/therapeutic use; Cyclohexanes/pharmacology; Cyclohexanes/therapeutic use; Drug Resistance, Viral; HIV Envelope Protein gp120/genetics; HIV Infections/drug therapy; Humans; Maraviroc

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Limits: Humans Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google